Home
MRK
MRK News

Latest Merck & Company Inc. (new) (MRK) News on July 7, 2025

FDA Grants Priority Review for Merck & Co’s (MRK) WINREVAIR

Insider Monkey

a day ago

FDA Grants Priority Review for Merck & Co’s (MRK) WINREVAIR

Merck & Co (MRK) Announces the Approval of ENFLONSIA

Insider Monkey

a day ago

Merck & Co (MRK) Announces the Approval of ENFLONSIA

Top Dividend Stocks To Consider In July 2025

Simply Wall St.

3 days ago

Top Dividend Stocks To Consider In July 2025

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?

Zacks

3 days ago

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?

Sodium Perborate Market worth $184.0 million in 2030, at 3.7%, says MarketsandMarkets™

GlobeNewswire

3 days ago

Sodium Perborate Market worth $184.0 million in 2030, at 3.7%, says MarketsandMarkets™

TD Cowen Maintains Hold Rating on Merck After Enflonsia Vaccine Update

Insider Monkey

3 days ago

TD Cowen Maintains Hold Rating on Merck After Enflonsia Vaccine Update

Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

3 days ago

Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade

Will The Decline in Legacy Drugs Pull Down BMY's Top Line?

Zacks

4 days ago

Will The Decline in Legacy Drugs Pull Down BMY's Top Line?

MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE

Zacks

4 days ago

MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE

Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth

Zacks

4 days ago

Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth

Merck & Co. (MRK) Announces that US FDA Approves ENFLONSIA™ For Preventing RSV Lower Respiratory Tract Disease

Insider Monkey

4 days ago

Merck & Co. (MRK) Announces that US FDA Approves ENFLONSIA™ For Preventing RSV Lower Respiratory Tract Disease

Merck's Drug Slashes PAH Risk by 76%--FDA Fast-Tracks Game-Changer

GuruFocus.com

4 days ago

Merck's Drug Slashes PAH Risk by 76%--FDA Fast-Tracks Game-Changer

MT Newswires

5 days ago

Merck's HPV Vaccine Gardasil Remains Key Driver Ahead of Q2 Results, UBS Says

Merck (NYSE:MRK) Gains FDA Priority Review For WINREVAIR PAH Treatment sBLA

Simply Wall St.

5 days ago

Merck (NYSE:MRK) Gains FDA Priority Review For WINREVAIR PAH Treatment sBLA

What's Fueling Tempus AI's Explosive Sales Growth?

Zacks

5 days ago

What's Fueling Tempus AI's Explosive Sales Growth?

MT Newswires

5 days ago

Merck Says FDA Granted Priority Review to New Supplemental Biologics License Application for Winrevair

Merck concludes SpringWorks acquisition for $3.4bn

Pharmaceutical Technology

5 days ago

Merck concludes SpringWorks acquisition for $3.4bn

FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial

Business Wire

5 days ago

FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial

Can China sustain a surge in oncology drug innovation?

Pharma Voice

5 days ago

Can China sustain a surge in oncology drug innovation?

Summit Therapeutics (SMMT) Rated Buy on Ivonescimab’s Cancer-Fighting Potential

Insider Monkey

5 days ago

Summit Therapeutics (SMMT) Rated Buy on Ivonescimab’s Cancer-Fighting Potential

Trading Rotation Kicks Off 2nd Half of 2025

Zacks

5 days ago

Trading Rotation Kicks Off 2nd Half of 2025

Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?

Zacks

6 days ago

Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?

Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29

Business Wire

6 days ago

Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29

BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?

Zacks

7 days ago

BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?

Investing.com

7 days ago

Gilead extends gains after Supreme Court upheld an Obamacare provision

Merck’s (MRK) WINREVAIR Shows Strong Results in HYPERION Trial

Insider Monkey

9 days ago

Merck’s (MRK) WINREVAIR Shows Strong Results in HYPERION Trial

Should You Count on MRK for Steady Passive Income?

Insider Monkey

9 days ago

Should You Count on MRK for Steady Passive Income?

Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations

GlobeNewswire

10 days ago

Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations

Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?

Zacks

10 days ago

Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?

Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

10 days ago

Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know

MT Newswires

11 days ago

Merck Says US CDC Committee Recommends Enflonsia in Infants As RSV Preventive Option

The Anti-Vax Movement Solidifies Control of the CDC’s Vaccine Committee

Barrons.com

11 days ago

The Anti-Vax Movement Solidifies Control of the CDC’s Vaccine Committee

ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season

Business Wire

11 days ago

ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season

Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?

Zacks

11 days ago

Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?

Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies

GlobeNewswire

11 days ago

Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies

2 Stocks Too Cheap to Ignore at These Prices

Motley Fool

11 days ago

2 Stocks Too Cheap to Ignore at These Prices

Stifel Downgrades Zoetis (ZTS) Stock, Reduces PT

Insider Monkey

12 days ago

Stifel Downgrades Zoetis (ZTS) Stock, Reduces PT

Will New Drugs Enable BMY to Offset the Impact of Generic Competition?

Zacks

12 days ago

Will New Drugs Enable BMY to Offset the Impact of Generic Competition?

Merck Moves Past 50-Day Average: How to Play MRK Stock Now

Zacks

12 days ago

Merck Moves Past 50-Day Average: How to Play MRK Stock Now

Jefferies Maintains a Buy Rating on Merck & Co. (MRK), Keeps the PT Unchanged

Insider Monkey

12 days ago

Jefferies Maintains a Buy Rating on Merck & Co. (MRK), Keeps the PT Unchanged

2 Cash-Producing Stocks for Long-Term Investors and 1 to Think Twice About

StockStory

12 days ago

2 Cash-Producing Stocks for Long-Term Investors and 1 to Think Twice About

Jefferies Reaffirms Merck (MRK) ‘Buy’ Rating on Gardasil Dosing Stability

Insider Monkey

12 days ago

Jefferies Reaffirms Merck (MRK) ‘Buy’ Rating on Gardasil Dosing Stability

MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal

Zacks

13 days ago

MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

Zacks

13 days ago

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?

Zacks

13 days ago

Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?

EXEL Stock Rises on Positive Data From Colorectal Cancer Study

Zacks

13 days ago

EXEL Stock Rises on Positive Data From Colorectal Cancer Study

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

Business Wire

13 days ago

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention

Business Wire

13 days ago

Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention

Brain Cancer Market Research Report 2025-2035 | Growing Shifts Toward Targeted Therapies and Immunotherapy Over Traditional Methods

GlobeNewswire

13 days ago

Brain Cancer Market Research Report 2025-2035 | Growing Shifts Toward Targeted Therapies and Immunotherapy Over Traditional Methods

Allergic Rhinitis Market Report 2025-2035 | Innovative Drug Classes and Regional Trends Propel Expansion

GlobeNewswire

13 days ago

Allergic Rhinitis Market Report 2025-2035 | Innovative Drug Classes and Regional Trends Propel Expansion

Merck Poised to Deliver Strong Results and Steady Dividend Growth

Insider Monkey

13 days ago

Merck Poised to Deliver Strong Results and Steady Dividend Growth

MT Newswires

14 days ago

Merck's Winrevair Meets Primary Endpoint in Phase 3 Study

Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension (PAH)

Business Wire

14 days ago

Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension (PAH)

The 5 Most Interesting Analyst Questions From Merck’s Q1 Earnings Call

StockStory

17 days ago

The 5 Most Interesting Analyst Questions From Merck’s Q1 Earnings Call

Why CareTrust, Merck, And Allete Are Winners For Passive Income

Benzinga

17 days ago

Why CareTrust, Merck, And Allete Are Winners For Passive Income

Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?

Zacks

18 days ago

Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?

2 Reasons to Watch MRK and 1 to Stay Cautious

StockStory

18 days ago

2 Reasons to Watch MRK and 1 to Stay Cautious

Why the Market Dipped But Merck (MRK) Gained Today

Zacks

18 days ago

Why the Market Dipped But Merck (MRK) Gained Today

Merck (NYSE:MRK) Begins Phase 3 Trial Of Innovative Prostate Cancer Treatment

Simply Wall St.

19 days ago

Merck (NYSE:MRK) Begins Phase 3 Trial Of Innovative Prostate Cancer Treatment

Trump administration weighs crackdown on pharma ads, Bloomberg says

TipRanks

19 days ago

Trump administration weighs crackdown on pharma ads, Bloomberg says

American Kidney Fund Launches Kidney Cancer Education Campaign

GlobeNewswire

19 days ago

American Kidney Fund Launches Kidney Cancer Education Campaign

MT Newswires

19 days ago

Merck Doses First Patient in Phase 3 Trial of Prostate Cancer Drug Candidate

IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer

Business Wire

19 days ago

IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer

Dividend Growth Remains a Key Priority for Merck

Insider Monkey

19 days ago

Dividend Growth Remains a Key Priority for Merck

MT Newswires

20 days ago

Market Chatter: Trump Administration to Consider Pharma Advertising Crackdown

Exiger CMO Kody Gurfein Wins PRNews' Top Women Award

PR Newswire

20 days ago

Exiger CMO Kody Gurfein Wins PRNews' Top Women Award

RFK Jr. Appointee To CDC Advisory Committee Was A Paid Expert In Merck's Gardasil Lawsuit

Benzinga

23 days ago

RFK Jr. Appointee To CDC Advisory Committee Was A Paid Expert In Merck's Gardasil Lawsuit

Senators to propose ban on drug ads to consumers, WSJ reports

TipRanks

24 days ago

Senators to propose ban on drug ads to consumers, WSJ reports

Citizens Financial, Merck, oil producers: Trending Tickers

Yahoo Finance Video

24 days ago

Citizens Financial, Merck, oil producers: Trending Tickers

Investors should be 'embracing volatility'

Yahoo Finance Video

24 days ago

Investors should be 'embracing volatility'

FDA Approves KEYTRUDA® (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiotherapy With or Without Cisplatin Then as a Single Agent

Business Wire

24 days ago

FDA Approves KEYTRUDA® (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiotherapy With or Without Cisplatin Then as a Single Agent

MSD begins Phase III trial of dengue vaccine

Clinical Trials Arena

24 days ago

MSD begins Phase III trial of dengue vaccine

Merck Animal Health Receives EU CVMP Positive Opinion for NUMELVI™ (atinvicitinib) Tablets for Dogs

Business Wire

24 days ago

Merck Animal Health Receives EU CVMP Positive Opinion for NUMELVI™ (atinvicitinib) Tablets for Dogs

MT Newswires

25 days ago

Merck Starts Phase 3 Trial of Dengue Vaccine

Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate

Business Wire

25 days ago

Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate

Merck’s Cholesterol Medication Achieves Primary Endpoint in Two Trials

Insider Monkey

25 days ago

Merck’s Cholesterol Medication Achieves Primary Endpoint in Two Trials

Merck & Co (MRK) RSV Antibody for Infants Approved by US FDA

Insider Monkey

a month ago

Merck & Co (MRK) RSV Antibody for Infants Approved by US FDA

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

TipRanks

a month ago

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

JNJ vs. MRK: Which Healthcare Titan Offers Better Growth Prospects?

Zacks

a month ago

JNJ vs. MRK: Which Healthcare Titan Offers Better Growth Prospects?

Morningstar Research

a month ago

Analyst Report: Merck & Co., Inc.

Merck (NYSE:MRK) Gains FDA Approval For RSV Treatment, Reports Positive Trial Results

Simply Wall St.

a month ago

Merck (NYSE:MRK) Gains FDA Approval For RSV Treatment, Reports Positive Trial Results

Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants

Zacks

a month ago

Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season

Business Wire

a month ago

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season

Merck's Cholesterol Lowering Drug Hits Primary Goal In Two Pivotal Trials

Benzinga

a month ago

Merck's Cholesterol Lowering Drug Hits Primary Goal In Two Pivotal Trials

Merck antibody drug for RSV approved by FDA

BioPharma Dive

a month ago

Merck antibody drug for RSV approved by FDA

Merck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults With Hyperlipidemia

Business Wire

a month ago

Merck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults With Hyperlipidemia

Merck claims study success with PCSK9 cholesterol pill

BioPharma Dive

a month ago

Merck claims study success with PCSK9 cholesterol pill

Challenges pharma companies face in push into US manufacturing

Yahoo Finance Video

a month ago

Challenges pharma companies face in push into US manufacturing

Analyst Says Merck (MRK) is ‘Really Cheap’ But Warns About Potential ‘Bad News’

Insider Monkey

a month ago

Analyst Says Merck (MRK) is ‘Really Cheap’ But Warns About Potential ‘Bad News’

Top Dividend Stocks To Consider In June 2025

Simply Wall St.

a month ago

Top Dividend Stocks To Consider In June 2025

MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout

Zacks

a month ago

MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout

Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next.

BioPharma Dive

a month ago

Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next.

PGR institution likely weakens Halozyme bull case scenario, says Wells Fargo

TipRanks

a month ago

PGR institution likely weakens Halozyme bull case scenario, says Wells Fargo

Merck granted review of Halozyme patent claims by PTAB

TipRanks

a month ago

Merck granted review of Halozyme patent claims by PTAB

Merck to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

Business Wire

a month ago

Merck to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

1 Value Stock to Target This Week and 2 to Question

StockStory

a month ago

1 Value Stock to Target This Week and 2 to Question

Constellation and Meta, Merck, Snowflake: Trending Tickers

Yahoo Finance Video

a month ago

Constellation and Meta, Merck, Snowflake: Trending Tickers

MoonLake Immunotherapeutics Catapults On Rumored $3 Billion Merck Takeover Bid

Investor's Business Daily

a month ago

MoonLake Immunotherapeutics Catapults On Rumored $3 Billion Merck Takeover Bid

Merck KGaA (MKGAF) Files for Global Approval of Pimicotinib After Positive Phase III TGCT Results – Updated

Insider Monkey

a month ago

Merck KGaA (MKGAF) Files for Global Approval of Pimicotinib After Positive Phase III TGCT Results – Updated

Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report

Benzinga

a month ago

Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report

Share on Social Networks: